Celcuity Management

Management criteria checks 4/4

Celcuity's CEO is Brian Sullivan, appointed in Jan 2012, has a tenure of 12.33 years. total yearly compensation is $1.74M, comprised of 12.1% salary and 87.9% bonuses, including company stock and options. directly owns 9.91% of the company’s shares, worth $49.17M. The average tenure of the management team and the board of directors is 3.3 years and 8.8 years respectively.

Key information

Brian Sullivan

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage12.1%
CEO tenure12.3yrs
CEO ownership9.9%
Management average tenure3.3yrs
Board average tenure8.8yrs

Recent management updates

Recent updates

Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Jul 04
Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Is Celcuity (NASDAQ:CELC) A Risky Investment?

Sep 13
Is Celcuity (NASDAQ:CELC) A Risky Investment?

Celcuity rises after hours on FDA Breakthrough Therapy nod for its breast cancer treatment

Jul 18

Is Celcuity (NASDAQ:CELC) A Risky Investment?

Jan 27
Is Celcuity (NASDAQ:CELC) A Risky Investment?

Health Check: How Prudently Does Celcuity (NASDAQ:CELC) Use Debt?

Sep 21
Health Check: How Prudently Does Celcuity (NASDAQ:CELC) Use Debt?

Celcuity: Nipping The Oncogenic Bud

Jul 08

What You Need To Know About Celcuity Inc.'s (NASDAQ:CELC) Investor Composition

Mar 14
What You Need To Know About Celcuity Inc.'s (NASDAQ:CELC) Investor Composition

We're Hopeful That Celcuity (NASDAQ:CELC) Will Use Its Cash Wisely

Jan 20
We're Hopeful That Celcuity (NASDAQ:CELC) Will Use Its Cash Wisely

Celcuity inks clinical trial pact with Massachusetts General Hospital and Puma Technologies

Dec 23

Could The Celcuity Inc. (NASDAQ:CELC) Ownership Structure Tell Us Something Useful?

Nov 29
Could The Celcuity Inc. (NASDAQ:CELC) Ownership Structure Tell Us Something Useful?

Celcuity EPS beats by $0.03

Nov 09

CEO Compensation Analysis

How has Brian Sullivan's remuneration changed compared to Celcuity's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$2mUS$210k

-US$64m

Sep 30 2023n/an/a

-US$57m

Jun 30 2023n/an/a

-US$49m

Mar 31 2023n/an/a

-US$45m

Dec 31 2022US$2mUS$106k

-US$41m

Sep 30 2022n/an/a

-US$36m

Jun 30 2022n/an/a

-US$31m

Mar 31 2022n/an/a

-US$35m

Dec 31 2021US$1mUS$260k

-US$30m

Sep 30 2021n/an/a

-US$25m

Jun 30 2021n/an/a

-US$22m

Mar 31 2021n/an/a

-US$10m

Dec 31 2020US$469kUS$250k

-US$9m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$8m

Dec 31 2019US$992kUS$250k

-US$7m

Sep 30 2019n/an/a

-US$7m

Jun 30 2019n/an/a

-US$7m

Mar 31 2019n/an/a

-US$7m

Dec 31 2018US$564kUS$250k

-US$7m

Sep 30 2018n/an/a

-US$7m

Jun 30 2018n/an/a

-US$7m

Mar 31 2018n/an/a

-US$7m

Dec 31 2017US$490kUS$232k

-US$6m

Compensation vs Market: Brian's total compensation ($USD1.74M) is about average for companies of similar size in the US market ($USD2.41M).

Compensation vs Earnings: Brian's compensation has been consistent with company performance over the past year.


CEO

Brian Sullivan (61 yo)

12.3yrs

Tenure

US$1,738,115

Compensation

Mr. Brian F. Sullivan is the Co-Founder of Celcuity Inc. and has been its Chairman and Chief Executive Officer since 2012 and served as its Chief Financial Officer. Mr. Sullivan Co-founded Entegris, Inc. i...


Leadership Team

NamePositionTenureCompensationOwnership
Brian Sullivan
Co-Founder12.3yrsUS$1.74m9.91%
$ 49.2m
Lance Laing
Co-Founder12.3yrsUS$1.48m4.1%
$ 20.4m
Vicky Hahne
Chief Financial Officer6.8yrsUS$898.74k0.054%
$ 269.9k
John MacDonald
Senior Vice President of R&D3.3yrsno datano data
Sheri Smith
Acting Head of Clinical Operations3.3yrsno datano data
Igor Gorbatchevsky
Chief Medical Officer2.2yrsno datano data
Eldon Mayer
Chief Commercial Officerless than a yearno datano data

3.3yrs

Average Tenure

61yo

Average Age

Experienced Management: CELC's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Brian Sullivan
Co-Founder12.3yrsUS$1.74m9.91%
$ 49.2m
Lance Laing
Co-Founder12.3yrsUS$1.48m4.1%
$ 20.4m
Richard Nigon
Independent Director7.3yrsUS$124.29k0.32%
$ 1.6m
David Dalvey
Independent Director10.3yrsUS$120.13k0.031%
$ 152.0k
Leo Furcht
Independent Director5yrsUS$108.82k0.034%
$ 171.2k
Ronald McGlennen
Member of Scientific Advisory Boardno datano datano data
Edward Greeno
Member of Scientific Advisory Boardno datano datano data
Sara A. Hurvitz
Member of Scientific Advisory Boardno datano datano data
Carol Lange
Member of Scientific Advisory Boardno datano datano data
Benita Katzenellenbogen
Member of Scientific Advisory Boardno datano datano data
John Katzenellengogen
Member of Scientific Advisory Boardno datano datano data
Mothaffar Rimawi
Member of Scientific Advisory Board5.3yrsno datano data

8.8yrs

Average Tenure

65yo

Average Age

Experienced Board: CELC's board of directors are considered experienced (8.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.